The Role of the Breast Cancer Resistance Protein (ABCG2) in the Distribution of Sorafenib to the Brain
Sagar Agarwal(Woomera Therapeutics), William F. Elmquist(University of Minnesota)
Cited by 159
Related Papers
Localized Metabolomic Gradients in Patient-Derived Xenograft Models of Glioblastoma
|Cancer Research|2019|99
Heterogeneous delivery across the blood-brain barrier limits the efficacy of an EGFR-targeting antibody drug conjugate in glioblastoma
|Neuro-Oncology|2021|81
Integrated mapping of pharmacokinetics and pharmacodynamics in a patient-derived xenograft model of glioblastoma
|Nature Communications|2018|79
Brain Distribution of a Panel of Epidermal Growth Factor Receptor Inhibitors Using Cassette Dosing in Wild-Type and Abcb1/Abcg2-Deficient Mice
|Drug Metabolism and Disposition|2019|49
CNS Anticancer Drug Discovery and Development Conference White Paper
|Neuro-Oncology|2015|45